Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katalyst Diagnostics is a UK-based private healthcare diagnostics company focused on point-of-care testing solutions for clinical and community settings. The company commercializes and distributes diagnostic devices and assays rather than developing therapeutics, with a portfolio centered on hematology, antipsychotic drug monitoring, and broader health-screening applications. Its offerings include the HemoScreen point-of-care full blood count analyzer and the MyCare INSITE system for rapid measurement of antipsychotic drug levels. Katalyst Diagnostics positions itself as a provider to the NHS and healthcare professionals seeking faster, more accessible, and workflow-friendly testing. The business appears to operate primarily as a commercial diagnostics distributor and solutions provider in the UK and Ireland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katalyst Diagnostics.